DAY301

· Day One Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DAY301, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing